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Liver cysts arising from hepatic bile ducts are a common extra-
renal pathology associated with both autosomal dominant and
recessive polycystic kidney disease in humans. To elucidate the
functional and structural changes inherent in cyst formation and
growth, hepatic bile duct epithelia were isolated from the BALB/
c-cpk mouse model of polycystic kidney disease. Light and
transmission electron microscopy revealed substantial fibrosis
in the basal lamina surrounding hepatic bile duct cysts isolated
from heterozygous (BALB/c-cpk/1) and homozygous (BALB/c-
cpk/cpk) animals. Scanning electron microscopy and length
analysis of normal, precystic and cystic bile ducts provided the
unique observation that primary cilia in cholangiocytes isolated
from bile ducts and cysts of animals expressing the mutated cpk
gene had lengths outside the minimal and maximal ranges of
those in cells lining bile ducts of wild-type animals. Based on the
hypothesis that PKD is one of several diseases characterized as
ciliopathies, this abnormal variability in the length of the primary
cilia may have functional implications. Electrophysiological
analyses of freshly isolated cysts indicate that the amiloride-
sensitive epithelial Na1 channel (ENaC) is inactive/absent and
cAMP-mediated anion secretion is the electrogenic transport
process contributing to cyst fluid accumulation. Anion secretion
can be stimulated by the luminal stimulation of adenylyl cyclase.
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Introduction
Polycystic kidney disease (PKD) is a genetic disorder
characterized by the growth of numerous fluid-filled cysts
predominately in the kidney and liver. There are two forms
of PKD which combined represent the third leading cause of
kidney failure in the United States (1, 2). Autosomal
Dominant Polycystic Kidney Disease (ADPKD), the most
common form, occurs at a rate of approximately 1 in 800 in
the human population and is usually diagnosed after the
fourth decade of life. Autosomal Recessive Polycystic
Kidney Disease (ARPKD) is a less common, but more
severe, disease that is typically diagnosed in neonates and
children. The primary cause of morbidity and mortality in
both forms of PKD is the progression of renal pathology.
The most common extra-renal manifestation of PKD is liver
cysts which arise from the cholangiocytes lining the hepatic
bile duct. As ARPKD progresses (adolescence to young
adults), liver disease becomes an important and severe
clinical finding. The cysts’ size and associated fibrosis can
affect organ function and quality of life. Most published
research has been devoted to studying the mechanisms
involved in renal cyst formation and comparatively little is
known about the processes that control the development and
maintenance of hepatic biliary cysts. This study addresses
this gap by examining structural features of cyst formation
as well as performing the first characterization of ion
transport across freshly isolated cystic biliary tissue.
ADPKD arises from mutations in one of 2 genes, PKD1
or PKD2, coding for integral membrane glycoproteins,
polycystin-1 and polycystin-2. The polycystins are found in
multiple sub-cellular sites including the primary cilium
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located on the apical membrane of polarized cells. ARPKD
arises from a mutation in PKHD1 which codes for another
cilia-associated protein, fibrocystin (1–3). Most rodent
models of PKD mimic the symptomatology of the disease
while expressing mutations in proteins other than the
polycystins or fibrocystin. Interestingly, the majority of
the genetic defects in the rodent models, as well as other
forms of cystic disease in humans, encode proteins that are
found in the primary cilium (1–5).
The proposed functions of the primary cilium include
roles in generation of left-right asymmetry during develop-
ment, in control of cell cycle progression and cell
proliferation, and in sensing and responding to, changes in
fluid flow and/or tonicity (6–10). In PKD, alteration of any
of these functions could theoretically be translated into
mechanisms which would contribute to the progression and
maintenance of fluid-filled cysts. In rodent models of PKD,
diverse changes in cilia structure have been noted. These
include shortened, malformed cilia as well as cilia which are
unusually long or entirely absent (5). The correlation, if any,
between ciliary structure and function in the context of PKD
disease progression is limited.
Recent studies have indicated similarities associated
with the development of kidney and liver cysts. Both
processes involve barrier epithelial cells lining either the
renal tubules or the biliary ducts, respectively. In these
tissues, cAMP can act as a mediator of ion transporters
involved in fluid homeostasis and as a mitogenic agent (10–
13). Emerging studies performed in both renal principal
cells and biliary cholangiocytes link changes in flow-
induced intracellular Ca2þ signaling, via the primary cilium,
to changes in intracellular cAMP concentrations (6, 12, 13).
The role of ion flux in the development of fluid-filled
renal cysts is well documented. Elegant studies performed
over a decade ago suggested that renal cyst formation in
ADPKD is driven by anion secretion (14–17). Inhibitor
studies and electrophysiological analyses indicated that
CFTR (cystic fibrosis transmembrane regulator), located in
the apical membrane, may be the ultimate Cl channel
responsible for the secretion while the NaþKþ2Cl triple co-
transporter, located in the basolateral membrane, is
responsible for the influx of Cl into the epithelial cells.
Ye and Grantham (14) isolated renal cysts from ADPKD
patients and measured net fluid movement under control and
forskolin stimulated conditions. Under unstimulated con-
ditions the cysts behaved as absorptive epithelia. The fluid
movement was reversed by forskolin, an activator of
adenylyl cyclase which increases intracellular cAMP and,
presumably, ion transport via CFTR. These findings were
extended by Grantham et al. to demonstrate that primary
cultures of cells isolated from human cysts also responded
to forskolin with an increase in fluid secretion into the cyst
lumen and that the fluid contained endogenous secreto-
gogues that could mimic the effect of forskolin (14, 16, 18).
The latter study indicates that, while stimulus-coupled anion
secretion may play a role in cyst formation and main-
tenance, the cyst fluid may contain additional contributing
factors.
Much less is known about the ion transport processes
that contribute to the formation and maintenance of the
hepatic biliary cysts. CFTR is present and active in bile duct
epithelial cells (19, 20). A single report has delineated the
ion transport characteristics of cultured liver cyst epithelial
cells (21). These investigators isolated epithelial cells from
the liver cysts of two different murine models of PKD, grew
the cells to confluence, and used electrophysiological
techniques to characterize the ion transport properties of
the resulting high resistance epithelial monolayers. Amilor-
ide sensitive absorptive Naþ flux was present in the cultured
cells indicating the presence of the epithelial Naþ channel
(ENaC). In addition, there was a substantial Cl secretory
response that was responsive to agonists that elevated
intracellular cAMP (21). The anion secretory response had
the characteristics of CFTR-mediated transport. In contrast,
Kirkland and colleagues found no amiloride sensitivity in
isolated gallbladder epithelia (22). To our knowledge, there
have been no studies examining the transport characteristics
of freshly isolated hepatic cyst wall epithelia.
The current studies have been performed to analyze
fibrotic changes, ciliary structure and transepithelial ion flux
during hepatic cyst development in the BALB/c-cpk mouse
model of PKD. The homozygous BALB/c-cpk/cpk animals
die of renal disease before maturity while the heterozygous
BALB/c-cpk/þ animals live to breeding age and after 12–18
months express biliary hepatic cysts which are similar to
those found in human ADPKD patients (23).
The initiation step for cyst formation is not completely
understood; however, there are three main components that
are consistently present during the process in both renal and
hepatic cysts: cellular proliferation, fluid accumulation and
structural changes to the extra-cellular matrix around the
cysts. To begin to understand these processes we have
compared the ultra-structural characteristics of the liver
cysts with normal bile duct epithelia to identify the degree
of cellular proliferation and fibrosis surrounding the cyst
epithelia. Electron microscopy and measurement of cilia
length were used to compare the primary cilia of cyst wall
epithelial cells with those found in normal and pre-cystic
bile ducts. Functionally, the characteristics of the trans-
epithelial ion transport in response to increases in intra-
cellular cAMP were measured in freshly isolated cyst wall
epithelia.
Materials and Methods
Mice. The cpk gene is expressed primarily in liver and
kidney and encodes the protein ‘‘cystin’’. BALB/c mice
homozygous for a cpk mutation (BALB/c-cpk/cpk) rapidly
develop polycystic kidney disease with the expression of a
multi-organ phenotype and die within 2–4 weeks (23).
Heterozygous animals (BALB/c-cpk/þ) have a relatively
normal life span and can be used for breeding. As
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heterozygote mice age, they begin to develop liver cysts
which are phenotypically similar to hepatic biliary cysts
observed in human ADPKD. The cysts range in size from
microscopic to the large fluid-filled masses seen in Figure 1.
After 12–18 months of age, these animals express multiple
large fluid-filled hepatic cysts that arise from the intra-
hepatic biliary system. The mice were bred at the Indiana
University School of Medicine laboratory animal resource
center and used under protocols approved by IACUC.
Electrophysiological Analysis of Ion Transport
in Isolated Liver Cyst Epithelia. Normal and cystic
BALB/c mice (;18 months of age) were euthanized (150
mg pentobarbital/Kg body weight) and perfused with
phosphate buffered saline (PBS). Large liver cysts from
BALB/c-cpk/þ mice were dissected free from surrounding
hepatic tissue, opened by peripheral cuts to form a single
sheet and mounted in a modified Ussing chamber. Cysts
used for electrophysiological measurements had tissue
sheets large enough to obtain a circular area of at least 1.3
cm in diameter. During the electrophysiological experi-
ments, the cystic tissue was bathed in serum-free Dulbec-
co’s modified Eagles medium/F12 media (DMEM)
(Invitrogen, Grand Island, NY), supplemented with 2.4
mg/L sodium bicarbonate (Fisher Scientific, Fair Lawn, NJ),
and 2 mM glutamine. The media was maintained at 378C,
with gentle circulation provided by a 5% CO2–95% O2 gas
lift. Electrodes inserted into the bathing media on either side
of the tissue allowed for the measurement of the sponta-
neous transepithelial potential difference (PD). Using a
current/voltage clamp, the PD was clamped to zero and the
resulting short circuit current (SCC), a measure of net
transepithelial ion transport, was recorded continuously. The
epithelial layers were monitored until a steady basal current
was obtained (20–60 mins). Effectors (from 1000X stock)
were added to the apical and/or serosal bathing medium as
indicated in the figures and the ion transport responses of the
tissue were measured. Agonist/inhibitors and final concen-
trations: Forskolin, 5 lM, is an activator of adenylyl
cyclase; 5-nitro-2-(3-phenylpropylamino)-benzoic acid
(NPPB), 100 lM, is a Cl channel blocker; and amiloride,
10 lM, is a specific inhibitor of ENaC.
Light and Electron Microscopy (EM). Cysts were
excised from the livers of the animals, immediately placed
in EM fixative (2% glutaraldehyde, 2% paraformaldehyde,
100 mM phosphate buffer, pH 7.4) and fixed overnight at
room temperature. The next day cysts were cut into smaller
pieces and returned to the EM fixative before embedment in
Epon812 resin for evaluation by light and electron micro-
scopy.
Light microscopy of 1 lm thick sections was used to
analyze structural differences and similarities between
normal and cystic tissue epithelia, and to provide an
overview of the area to be viewed using electron micro-
scopy. Electron microscopy was performed to analyze the
structural differences between the cystic epithelial cells in
contrast to normal bile duct cholangiocytes. For trans-
mission electron microscopy (TEM), tissues were post-fixed
in 1% osmium tetroxide for 1 hr, rinsed, and dehydrated in
graded ethanol solutions and propylene oxide resin of 1:3,
1:1 and 3:1 and left overnight before being embedded in
Epon812 and allowed to polymerize at 608C for 24 hrs.
Semi-thick (1 lm) resin sections were cut and stained with
Toluidine blue and visualized with a light microscope. Thin
sections (60 nm/80 nm) were cut, stained with uranyl acetate
and lead citrate and visualized on a Tecnai G12 TEM (FEI,
Hillsboro, Oregon).
Samples to be visualized using scanning electron
microscope (SEM) were rinsed in PBS, incubated in 1%
osmium tetroxide for 1 hr, rinsed in distilled water,
dehydrated in graded ethanol solutions and then dried using
a Tousimis Samdri 790 critical point drier, with liquid CO2
as the transitional fluid. After drying, samples were mounted
onto stubs, coated with a gold/palladium (Au/Pd) by a
Polaron direct sputter coater and viewed with a JEOL JSM
6390 scanning EM (JEOL USA Inc., Peabody, MA).
Micrographs were taken at appropriate magnifications. Cilia
length was determined from the SEM micrographs with the
aid of Scandium program (Sift Imaging Systems, Lake-
wood, CO).
Figure 1. Photographs of an 18 month old male BALB/c-cpk/þ mouse showing an increase in abdominal girth (A) due to the presence of
extensive liver cysts (B).
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Results
At approximately 1–1.5 years of age BALB/c-cpk/þ
mice (male/female) exhibit abdominal distention as a result
of the expansion of the hepatic cysts (Fig. 1A). There are
multiple cysts of varying sizes in the hepatic biliary tree
(Fig. 1B).
Structural Comparisons of Normal and Cystic
Hepatic Bile Ducts. At the light microscope level, a
comparison of normal appearing bile ducts with hepatic
biliary cysts, which are formed from the same cell type,
clearly shows the cellular proliferation necessary for the
increase in luminal diameter that takes place during cyst
formation (Fig. 2). The number of epithelial cells lining the
cysts is several fold more than the cells lining the normal
bile duct. Another striking aspect of the cysts is the amount
of fibrosis associated with the cystic epithelia.
Transmission electron microscopy (TEM) images of
normal appearing bile ducts from wild-type, heterozygous
and homozygous mice are shown in Figure 3. In general, the
majority of the bile ducts in mice carrying one or two copies
of the aberrant cpk gene are enlarged. Even those that
appear relatively normal in size likely represent the ‘‘pre-
cystic’’ state, a supposition that is supported by the
homozygous bile duct in Figure 3 where cell division is
occurring even though the bile duct is lined with a confluent
layer of epithelial cells. Interestingly, the cell that is dividing
in the upper portion of the duct appears to be separating in a
circumferential direction which may be indicative of loss of
planar cell polarity, a defect seen in models of PKD.
Scanning electron microscopic (SEM) analysis reveals
the primary cilia found in both the bile ducts and in the cysts
of affected animals (Fig. 4). The representative micrographs
Figure 2. Light microscopic images of liver sections showing normal and cystic bile ducts of heterozygous (BALB/c-cpk/þ) and homozygous
(BALB/c-cpk/cpk) mice. All images were taken with a340 objective. The bile ducts/cysts are generally closely associated with the portal triads
(bile duct-B, portal vein-V and hepatic artery branch-A). The cystic bile ducts (right) from both the cpk/þ heterozygotes (top) and cpk/cpk
homozygotes (bottom) are associated with an increase in periportal fibrosis.
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of cystic epithelia show large differences in ciliary length
within the same cyst. To provide a more quantitative
analysis of potential ciliary differences, the length of the
cilia from multiple animals were measured and the data are
expressed as a percentage of the total in various length
classifications. The category of lengths from 1–4 lm
contains 93% of the wild-type cilia (Fig. 5). In general,
many of the epithelial cells in bile ducts and cysts from
heterozygous and homozygous animals possessed cilia that
were either shorter or longer than those observed in bile
ducts from wild-type animals.
Careful examination of SEM micrographs identified
structural differences between certain epithelia isolated from
the same liver cyst (compare Fig. 6A and B). In one area
(Fig. 6A) epithelia had a domed appearance accompanied
by numerous long cilia. However, another area in the same
cyst possessed cells with a flattened phenotype accompanied
by very short or absent cilia (Fig. 6B).
Ion Transport Properties of Cyst Epithelia. Elec-
trophysiological experiments were performed on isolated cyst
wall epithelia from the largest of the biliary liver cysts (Fig. 7).
The cysts are formed of a low resistance epithelial layer (all 5
experimental tissues have resistances between 30 and 40
Xcm2). The cholangiocytes which line the cysts showed
electrogenic ion secretion in response to forskolin, an agent
known to increase intracellular cAMP. The first panel (Fig.
7A) illustrates a response when forskolin was added to both
the luminal and serosal sides of the epithelia. The increase in
SCC represents either an increase in cationic movement in an
absorptive direction (luminal to basal) or anionic movement
in a secretory direction (basal to luminal). In contrast to most
other epithelial cells where adenylyl cyclase (the protein
target activated by forskolin) is associated with receptors on
the basolateral membrane, forskolin was ineffective when
added to the serosal face of the monolayer but was always
effective when added to the apical side (Fig. 7B, representa-
tive of 5 out of 5 experiments).
Inhibitors of ion channels previously allied with
transport in renal cysts were used to determine the nature
of the SCC. Ion transport was not inhibited by amiloride, a
specific ENaC blocker, indicating that Naþ reabsorption
does not contribute to basal or forskolin stimulated ion
transport. 5-nitro-2-(3-phenylpropylamino)-benzoic acid
(NPPB), a Cl channel blocker, inhibited trans-epithelial
transport but only when added to the apical side of the
epithelial sheet indicating that in the cholangiocytes, like the
renal cells, the anion channels are in the apical membrane.
Based on data suggesting a role for CFTR in renal
cystogenesis, it is likely that the chloride channel involved
in the biliary cysts is also CFTR.
The two experiments shown in Figure 7 are represen-
tative of 5 such experiments. In all 5, the absence of
amiloride sensitivity was consistent. The figures shown
were selected to illustrate the variability in basal transport
rates (from 7–40 lA/cm2) as well as the differences in the
percentage of the final current which was inhibited by
NPPB.
Discussion
Treatment of PKD requires an understanding of the
Figure 3. TEM of bile ducts/cysts from BALB/c-cpk mice. The relatively normal sized bile ducts in adult heterozygous mice (center) and suckling
homozygous mice (right) are lined by cuboidal epithelial cells similar in appearance to those seen in adult normal (wild-type,þ/þ) mice. However
the ducts from these cystic mice generally have more cells per duct cross-section and exhibit evidence of increased proliferative activity (mitosis
in panel on the right). All figures are the same magnification.
ANALYSIS OF LIVER CYSTS FROM THE BALB/C-CPK PKD MOUSE MODEL 21
 at SAGE Publications on November 3, 2014ebm.sagepub.comDownloaded from 
processes involved in the development and maintenance of
the renal and extra-renal cysts. One of the most promising
leads in the search for therapeutic agents to treat the renal
pathology of both the autosomal dominant and recessive
forms of polycystic kidney disease is the vasopressin V2
receptor antagonist OPC31260. In three different animal
models of renal cystic disease, treatment with the antagonist
decreased cAMP levels, prevented renal enlargement,
inhibited cystogenesis and protected renal function by
halting progression of renal disease (24, 25). Development
of biliary cysts may share common features with the
biochemical processes involved in renal cyst formation and
this information can be used to develop similar treatment
strategies for hepatic cystic disease. In both cases cyst
formation involves the epithelial cells lining the renal tubule
or the cholangiocytes of the intrahepatic bile ducts. Previous
studies combined with the current data show that both may
involve cAMP-mediated ion transport.
The BALB/c-cpk/cpk mouse is a model of ARPKD
which expresses renal as well as extra-renal pathology. The
homozygous affected mice live only 2–4 weeks. However, the
heterozygous animals (BALB/c-cpk/þ) used for breeding
Figure 4. SEM of bile ducts/cysts from BALB/c-cpk mice. The micrographs of bile ducts from normal, heterozygous-cpk/þ and homozygous-
cpk/cpk mice (top micrographs) all possess ciliated epithelia; however, the cilia in the normal mice all appear roughly the same length while cilia
in heterozygous and homozygous mice are quite variable in length. In the cysts from heterozygous and homozygous mice (bottom
micrographs), the variability in cilia length is very obvious, from being almost non evident to cilia that are very long.
22 MUCHATUTA ET AL
 at SAGE Publications on November 3, 2014ebm.sagepub.comDownloaded from 
show some interesting pathology. Older heterozygous mice
(12–18 months) develop intra-hepatic bile duct cysts which
are phenotypically similar to the multiple, large, hepatic
biliary cysts observed in human ADPKD (23). The phenotypic
presentation of the liver cysts in this model is dominated by
extracellular fibrosis, particularly in the tissues immediately
surrounding the cysts. Our results are similar to Hou et al.,
who reported extracellular fibrosis surrounding the renal cysts
in C57BL/6J model of PKD (3). Proliferative changes may be
enhanced by the presence of proto-oncogenes in PKD (26).
Structural and functional differences in the primary
cilium have been implicated in both renal and hepatic cystic
disease. The primary cilium, a ubiquitous structure,
particularly on polarized epithelial cells, contains a surpris-
Figure 5. Cilia length distribution. Length was determined for the following numbers of cilia in each category: Wild-type, 121; heterozygous bile
ducts, 76; homozygous bile ducts, 173; heterozygous cysts, 185; homozygous cysts, 219. The bars represent the percentages of the total within
each of the length categories indicated.
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ingly large number of proteins (27, 28). Of note are the
findings that the majority of the proteins known to be
involved in human and mammalian PKD are co-localized to
this single large apical appendage or to the basal body at the
cilium-cellular interface (5, 29). Exogenous expression
studies of the cpk gene, whose mutation results ARPKD,
showed the cpk gene product to be localized to the central
cilia in polarized renal epithelia. Interestingly, another cilia-
associated protein, Polaris, also co-localizes with cystin in
the cilia (3). These findings suggest that the functionality of
the cilia plays a major role in cystogenesis. There are other
disease entities which exhibit mutations in proteins that
reside in the primary cilium and many of these diseases also
express cyst formation in kidney, liver and other organs.
The most notable of these diseases are Nephronophthsis
(NPHP), Meckel-Gruber Syndrome and Bardet-Biedl Syn-
drome. In the latter, a mutation in one of a complex of
trafficking proteins of the cilium causes a wide range of
organ dysfunction (4, 30).
Recently Masyuk and colleagues (31) have convinc-
ingly characterized the cholangiocyte cilium as a sensory
organelle which can detect changes in luminal bile duct
flow. Changes in flow are communicated to other cellular
response elements via changes in intracellular Ca2þ and
cAMP concentrations. Increased flow causes a cilium-
dependent rise in intracellular Ca2þ followed by a decrease
in cAMP via a Ca2þ inhibitable adenylyl cyclase (AC6)
which, interestingly, is also localized within the cilium (6).
The apical localization of AC6 is entirely consistent with the
apical effectiveness of forskolin, an adenylyl cyclase
activator in the excised cyst epithelium. These data also
suggest that components present in cyst fluid that bathes the
apical surface may modulate electrolyte and compensatory
fluid secretion into the cyst.
Since the primary cilium is thought to act as both a flow
sensor and, potentially, an effector of ion transport, changes
in ciliary structure may accompany important, as of yet
unknown, alterations in ciliary function. In rodent models of
PKD, diverse changes in ciliary structure have been
previously noted. These include shortened, malformed cilia,
multiciliated epithelial cells, as well as cilia which are
unusually long or entirely absent (5). The reason for
apparent discrepancies in the various models could result
from inherent variability due to the fact that the underlying
mutations are quite different. However, in the current
experiments, we have noted that in both bile ducts and liver
cysts there is a range of ciliary length, both shorter and
longer, compared to those seen in wild-type ductal epithelia.
For example, in heterozygous animals, there is an increase
in the percentage of cilia that are less than 1 lm in length—
15% in bile ducts and 14% in liver cysts as compared to 2%
in wild-type controls. This trend is also seen in homozygous
animals where 11% of bile duct cilia and 3% of cilia from
cystic epithelia are less than 1 lm in length.
Cilia on epithelial bile duct cells in wild-type mice fall
predominately within the range of 1–4 lm with none of the
121 cilia counted having a length over 6 lm. This is in
excellent agreement with the studies of Brown and Murcia
who showed that in normal mouse renal cells, the majority
of the cilia were 1–2 lm with no cilia over 4 lm in length
(9). In contrast 20% of the cilia in heterozygous mice bile
ducts, 26% in heterozygous cysts and 6% of cilia in
homozygous mice cysts were over 6 lm. Given the finding
that cystic cholangiocytes have both shorter and longer cilia
than are seen in normal cholangiocytes, the mean length is
less important than is the length distribution in the
characterization of ciliary abnormalities. The relative
Figure 6. Ciliated and non-ciliated cholangiocyte cellular morphol-
ogy. A. This micrograph depicts an area of a large cyst isolated from
a BALB/c-cpk/þ mouse that contains predominately ciliated chol-
angiocytes expressing central cilia with lengths longer than those
found in normal, wild-type bile ducts. This micrograph was obtained
from the same cyst as that shown in panel B. B. This micrograph
depicts an area of a large cyst isolated from a BALB/c-cpk/þmouse
that contains predominately non-ciliated cholangiocytes that express
central cilia with lengths shorter than those found in normal, wild-type
bile ducts. This micrograph was obtained from the same cyst as that
shown in panel A.
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similarities between the cilia length distribution in hetero-
zygous and homozygous animals may relate to the possible
loss of function of the normal cpk allele in the cells lining
the cysts of the heterozygous mice whereby they express
only the mutant cpk allele (32).
One possible explanation for the preponderance of very
short or absent cilia is that the cystic and pre-cystic epithelia
are strongly proliferative. The primary cilium is grounded in
one of the two basal bodies which become centrioles needed
during mitosis. Hence, in dividing cells, there is ciliary
resorption and shortening during the G2/M phase of the cell
cycle (7). The excess of longer than normal cilia is
intriguing. More studies will be necessary to determine
whether this is a cause or consequence of cyst formation.
However, the large number of very long cilia, particularly in
the bile ducts of the heterozygous animals, suggests that the
length may contribute to the development of cysts.
Sheets of liver cyst wall can be successfully isolated
from heterozygous animals and used in electrophysiological
studies to examine electrogenic transepithelial transport
characteristics. The cholangiocytes that line the biliary duct
cysts are responsible for the secretion of ions and fluid into
the cyst cavity. Therefore, a careful characterization of the
ion transport proteins and an elucidation of some of the
intracellular biochemical pathways controlling the activity
of the channels forms an important background for under-
standing cyst development and maintenance. The basal level
of electrogenic ion flux in the isolated cholangiocyte-lined
tissues showed considerable variation. This variation is
unlikely to be due to the size of the cysts since only the
largest of these could be used for electrophysiological
experiments. Additional experiments will be necessary to
determine if the differences are the result of factors such as
cilia length, and/or level of transport protein abundance.
In contrast to cultured epithelia from cyst walls (21), the
freshly isolated cystic epithelia were unresponsive to
amiloride, a specific inhibitor of the epithelial Naþ channel,
ENaC. These results suggest that electrogenic Naþ reabsorp-
tion does not contribute to basal or forskolin-stimulated ion
transport ex vivo and possibly in vivo. The differences between
the amiloride sensitivity in the cultured cells versus the freshly
isolated tissue may be explicable, in part, by the conditions
necessary to grow cells in primary culture. These conditions
generally include culture media with high levels of steroids
(dexamethasone), growth factors (epidermal growth factor),
pituitary extract, triiodothyrodine, insulin and forskolin—all
factors that are known to regulate ENaC synthesis and/or
activity. Alternatively, it has been suggested that the state of
differentiation may change over time in primary culture (33).
NPPB inhibits transepithelial transport but only when
added to the apical side of the epithelial sheet. NPPB
inhibits multiple transport proteins; however, it is often used
as an inhibitor of CFTR. The inhibition on the apical side is
consistent with the expected apical localization of the CFTR
Cl channel where it can secrete anions into the cyst lumen.
Forskolin, an agent that activates adenylyl cyclase and
thereby increases intracellular cAMP concentrations, in-
creases net electrogenic transport with a directionality that is
consistent with an increase in either cation absorption or
anion secretion. Because the process is inhibited by NPPB
but not amiloride, forskolin is likely causing an increase in
Cl secretion. There is, however, one unusual observation in
these experiments. The forskolin is effective when added to
the apical membrane. In many epithelial cells, adenylyl
cyclase is localized to the serosal compartment where it is in
contact with peptide hormone receptors resident in the
basolateral membrane. For this reason, forskolin is usually
effective from the serosal bathing media, not the apical. Our
data are, as noted above, consistent with the recent
observation by Masyuk et al. that adenylyl cyclase 6 is
Figure 7. Electrophysiology of biliary epithelia lining the liver cysts found in BALB/c-cpk/þmice. The epithelium in each panel represents a large
liver cyst (each from a different mouse). Tissue was mounted in Ussing chambers and maintained under voltage clamp conditions at 378C. SCC,
the short circuit current, is a measure of net transepithelial, electrogenic ion transport. Panel B shows the specific sidedness of the agonists/
inhibitors applied to the cyst epithelia. Effectors were added to the bathing media to achieve final concentrations of: amiloride, 10 lM; forskolin, 5
lM; NPPB, 100 lM.
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found in cholangiocyte primary cilia on the apical surface
(6). As such, this enzyme is a target for agents that increase
anion secretion. Alternatively, the supporting, fibrous
membranes surrounding the basolateral surface of the
epithelial monolayers may form a barrier for the diffusion
of the forskolin.
Our studies have, for the first time, demonstrated the
ion transport characteristics of freshly isolated bile duct
cystic epithelia. The results indicate the remarkable
similarity between the biliary and renal cystic tissue.
However, the absence of vasopressin, V2, receptors in
cholangiocytes means that, unlike the renal principal cells,
antidiuretic hormone will not be an endogenous ligand
stimulating increases in intracellular cAMP. Thus, the V2
receptor antagonists will not be effective for treating the
hepatic manifestations of PKD. However, in the PCK rat
model of ARPKD, octreotide, an analogue of somatostatin
appears to be effective in inhibiting cAMP levels and
reducing cyst growth (34). Our data are consistent with this
finding and provide additional support for the proposed
mechanism of drug action.
In summary, our results indicate that the cholangiocytes
lining the hepatic bile ducts exhibit a diverse range of
primary cilia lengths, which are outside the normal minimal
and maximal ranges in wild-type animals. This may
contribute to the observed differences in cellular morphol-
ogy and/or cellular ion transport observed in the cystic
epithelia. With regard to ion transport, our studies are the
first to use ex vivo tissue to demonstrate ion secretory flux,
which is consistent with cyst enlargement via compensatory
fluid movement. The observation that apical activation of
adenylyl cyclase is a stimulus for ion flux suggests that the
components of the cyst fluid may contribute to cyst
enlargement.
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